Cargando…

Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation

Post-liver transplantation tumor recurrence is a major challenge for hepatocellular carcinoma (HCC) recipients. We aimed to identify early-phase circulating microRNAs after liver transplantation for predicting tumor recurrence and survival of HCC recipients. Circulating microRNA profiles at early-ph...

Descripción completa

Detalles Bibliográficos
Autores principales:	NG, Kevin Tak-Pan, Lo, Chung Mau, Wong, Nathalie, Li, Chang Xian, Qi, Xiang, Liu, Xiao Bing, Geng, Wei, Yeung, Oscar Wai-Ho, Ma, Yuen Yuen, Chan, See Ching, Man, Kwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991421/ https://www.ncbi.nlm.nih.gov/pubmed/26918346 http://dx.doi.org/10.18632/oncotarget.7627

Ejemplares similares

Clinical significance and therapeutic value of glutathione peroxidase 3 (GPx3) in hepatocellular carcinoma
por: Qi, Xiang, et al.
Publicado: (2014)

Clinical significance and functional role of transmembrane protein 47 (TMEM47) in chemoresistance of hepatocellular carcinoma
por: Ng, Kevin Tak-Pan, et al.
Publicado: (2020)

The Clinical Significance and Potential Therapeutic Role of GPx3 in Tumor Recurrence after Liver Transplantation
por: Qi, Xiang, et al.
Publicado: (2016)

FTY720 Suppresses Liver Tumor Metastasis by Reducing the Population of Circulating Endothelial Progenitor Cells
por: Li, Chang Xian, et al.
Publicado: (2012)

A hemoglobin-based oxygen carrier sensitized Cisplatin based chemotherapy in hepatocellular carcinoma
por: Qi, Xiang, et al.
Publicado: (2017)

Type III TGF-β Receptor Down-Regulation Promoted Tumor Progression via Complement Component C5a Induction in Hepatocellular Carcinoma
por: Yeung, Oscar Wai Ho, et al.
Publicado: (2021)

Glutathione Peroxidase 3 Delivered by hiPSC-MSCs Ameliorated Hepatic IR Injury via Inhibition of Hepatic Senescence
por: Qi, Xiang, et al.
Publicado: (2018)

Repressor and activator protein accelerates hepatic ischemia reperfusion injury by promoting neutrophil inflammatory response
por: Li, Chang Xian, et al.
Publicado: (2016)

A Garlic Derivative, S-allylcysteine (SAC), Suppresses Proliferation and Metastasis of Hepatocellular Carcinoma
por: Ng, Kevin T. P., et al.
Publicado: (2012)

A novel oxygen carrier “YQ23” suppresses the liver tumor metastasis by decreasing circulating endothelial progenitor cells and regulatory T cells
por: Li, Chang Xian, et al.
Publicado: (2014)

Interferon-gamma inducible protein 10 (IP10) induced cisplatin resistance of HCC after liver transplantation through ER stress signaling pathway
por: Geng, Wei, et al.
Publicado: (2015)

FTY720 Suppresses Liver Tumor Growth and Metastasis by Reducing Circulating Regulating T Cells and Enhancing the Anti-Tumor Effect of Rapamycin
por: Li, Chang Xian, et al.
Publicado: (2020)

Glutathione S-transferase A2 promotes hepatocellular carcinoma recurrence after liver transplantation through modulating reactive oxygen species metabolism
por: Ng, Kevin Tak-Pan, et al.
Publicado: (2021)

The heterogeneity of plasma miRNA profiles in hepatocellular carcinoma patients and the exploration of diagnostic circulating miRNAs for hepatocellular carcinoma
por: Bai, Xue, et al.
Publicado: (2019)

Monocytic MDSC mobilization promotes tumor recurrence after liver transplantation via CXCL10/TLR4/MMP14 signaling
por: Liu, Hui, et al.
Publicado: (2021)

Circulating miRNAs in sepsis—A network under attack: An in-silico prediction of the potential existence of miRNA sponges in sepsis
por: Vasilescu, Catalin, et al.
Publicado: (2017)

Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region
por: Zhu, Ran Xu, et al.
Publicado: (2016)

Role of Portal Vein Embolization in Hepatocellular Carcinoma Management and Its Effect on Recurrence: A Case-control Study
por: Siriwardana, Rohan C., et al.
Publicado: (2012)

Arachidonic acid activates NLRP3 inflammasome in MDSCs via FATP2 to promote post-transplant tumour recurrence in steatotic liver grafts
por: Liu, Hui, et al.
Publicado: (2023)

Late Recurrence of Hepatocellular Carcinoma after Liver Transplantation
por: Chok, Kenneth S. H., et al.
Publicado: (2011)

Genome-Wide Association Study of Hepatocellular Carcinoma in Southern Chinese Patients with Chronic Hepatitis B Virus Infection
por: Chan, Kelvin Yuen-Kwong, et al.
Publicado: (2011)

The Impact of Liver Graft Injury on Cancer Recurrence Posttransplantation
por: Li, Chang-Xian, et al.
Publicado: (2017)

Circulating miRNAs as Biomarkers for Neurodegenerative Disorders
por: Grasso, Margherita, et al.
Publicado: (2014)

Circulating miRNAs as biomarkers of kidney disease
por: Hüttenhofer, Alexander, et al.
Publicado: (2017)

Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures
por: Duttagupta, Radha, et al.
Publicado: (2011)

Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases
por: Katoh, Masaru
Publicado: (2014)

Risk Factors and Post-Resection Independent Predictive Score for the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma
por: Hung, Ivan Fan-Ngai, et al.
Publicado: (2016)

EBV–encoded miRNAs can sensitize nasopharyngeal carcinoma to chemotherapeutic drugs by targeting BRCA1
por: Lung, Raymond Wai‐Ming, et al.
Publicado: (2020)

Development of cisplatin-loaded hydrogels for trans-portal vein chemoembolization in an orthotopic liver cancer mouse model
por: Yang, Xinxiang, et al.
Publicado: (2021)

Circulating cell-free miRNAs as biomarker for triple-negative breast cancer
por: Shin, V Y, et al.
Publicado: (2015)

Exosome-Derived miRNAs as Potential Biomarkers for Prostate Bone Metastasis
por: Lu, Zhenquan, et al.
Publicado: (2022)

The Landscape of Aberrant Alternative Splicing Events in Steatotic Liver Graft Post Transplantation via Transcriptome-Wide Analysis
por: Liu, Hui, et al.
Publicado: (2023)

MiRNAs as Novel Adipokines: Obesity-Related Circulating MiRNAs Influence Chemosensitivity in Cancer Patients
por: Withers, Sarah B., et al.
Publicado: (2020)

Circulating miRNAs as diagnostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance
por: Li, Jia, et al.
Publicado: (2020)

The Role of Proline Rich Tyrosine Kinase 2 (Pyk2) on Cisplatin Resistance in Hepatocellular Carcinoma
por: Geng, Wei, et al.
Publicado: (2011)

Use of Liver Stiffness Measurement for Liver Resection Surgery: Correlation with Indocyanine Green Clearance Testing and Post-Operative Outcome
por: Fung, James, et al.
Publicado: (2013)

Circulating miRNAs as Potential Marker for Pulmonary Hypertension
por: Wei, Chuanyu, et al.
Publicado: (2013)

Methodological challenges in utilizing miRNAs as circulating biomarkers
por: Moldovan, Leni, et al.
Publicado: (2014)

Circulating miRNAs: cell–cell communication function?
por: Turchinovich, A., et al.
Publicado: (2013)

Circulating miRNAs in cancer: from detection to therapy
por: Wang, Wen-Tao, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_s5ht8heu71eanorbi3ejk88mc2